Manufacturer: Alpha Pharma
Category: Anti Estrogens
Substance: Clomiphene citrate (Clomid)
Package: 50mg (50 pills)
In terms of chemical composition and properties, Clomid Promifen resembles estrogens, acts on estrogen receptors in the ovaries and pituitary gland and causes a surge in the activity of releasing hormones (luteinizing and follicle-stimulating gomons).
This reaction in turn affects the increase in testosterone levels.
Clomid Promifen prevents the occurrence of side effects caused by estrogen – in particular, gynecomastia (female-type breast enlargement).
Taking Clomid after anabolic courses is extremely important for the regulation of internal hormonal processes.
Application and dosage
Duration of reception of Clomid Promifen is 7-10 days, maximum – 2 weeks. To use Clomid as a post-course therapy drug (PCT), athletes usually start 7-10 days after taking anabolic drugs.
The recommended dose is 50-100 mg per day (these are 1-2 tablets).
It is better to take Clomid once a day after meals with water.
If the reception starts with 100 mg per day, after five days of the course it is better to reduce the dose to 50 mg.
Since Clomid contributes to the development of natural testosterone, the drug is used with maximum caution – without exceeding the recommended dosages.
In some cases, Clomid is used not after, but directly during the period of anabolic courses – this approach is appropriate when the courses have a longer duration.
You can also add 40-60 mg of tamoxifen per day – this is if the course of steroids has been long.
Side effects and contraindications
Clomid is contraindicated in case of renal or hepatic insufficiency, tumors or hypofunction (excessive activity) of the pituitary, individual intolerance of the substances making up the preparation.
Excess doses may cause headache, insomnia, nausea, slowing of motor or mental reactions. In rare cases, allergic reactions may occur.
Alpha-Pharma Clomid is an affordable and relatively safe drug needed for rehabilitation after anabolic courses.
There are no reviews yet.